JP2024541995A5 - - Google Patents

Info

Publication number
JP2024541995A5
JP2024541995A5 JP2024525415A JP2024525415A JP2024541995A5 JP 2024541995 A5 JP2024541995 A5 JP 2024541995A5 JP 2024525415 A JP2024525415 A JP 2024525415A JP 2024525415 A JP2024525415 A JP 2024525415A JP 2024541995 A5 JP2024541995 A5 JP 2024541995A5
Authority
JP
Japan
Prior art keywords
independently
alkyl
disease
halogen
structural part
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024525415A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024541995A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/079344 external-priority patent/WO2023081854A1/en
Publication of JP2024541995A publication Critical patent/JP2024541995A/ja
Publication of JP2024541995A5 publication Critical patent/JP2024541995A5/ja
Pending legal-status Critical Current

Links

JP2024525415A 2021-11-05 2022-11-04 Akt3モジュレーター Pending JP2024541995A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163276338P 2021-11-05 2021-11-05
US63/276,338 2021-11-05
PCT/US2022/079344 WO2023081854A1 (en) 2021-11-05 2022-11-04 Akt3 modulators

Publications (2)

Publication Number Publication Date
JP2024541995A JP2024541995A (ja) 2024-11-13
JP2024541995A5 true JP2024541995A5 (cg-RX-API-DMAC10.html) 2025-11-11

Family

ID=86242245

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024525415A Pending JP2024541995A (ja) 2021-11-05 2022-11-04 Akt3モジュレーター

Country Status (10)

Country Link
US (1) US20250002511A1 (cg-RX-API-DMAC10.html)
EP (1) EP4426279A4 (cg-RX-API-DMAC10.html)
JP (1) JP2024541995A (cg-RX-API-DMAC10.html)
KR (1) KR20240114792A (cg-RX-API-DMAC10.html)
CN (1) CN118524833A (cg-RX-API-DMAC10.html)
AU (1) AU2022382397A1 (cg-RX-API-DMAC10.html)
CA (1) CA3236920A1 (cg-RX-API-DMAC10.html)
IL (1) IL312442A (cg-RX-API-DMAC10.html)
MX (1) MX2024005269A (cg-RX-API-DMAC10.html)
WO (1) WO2023081854A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021212111A1 (en) * 2020-04-17 2021-10-21 Augusta University Research Institute, Inc. Compositions and methods for treating leukemia
WO2024251212A1 (en) * 2023-06-06 2024-12-12 Revir Therapeutics, Inc. Isoindolinone and dihydropyrrolopridinone compounds and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1751136B1 (en) * 2004-05-07 2014-07-02 Amgen Inc. Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
EP2078008A2 (en) * 2006-10-12 2009-07-15 SuperGen, Inc. Quinoline derivatives for modulating dna methylation
US7790746B2 (en) * 2007-10-12 2010-09-07 Supergen, Inc. Quinoline derivatives for modulating DNA methylation
US10292978B2 (en) * 2016-01-15 2019-05-21 Augusta University Research Institute, Inc. Specific Akt3 inhibitor and uses thereof
US10342868B2 (en) * 2016-01-15 2019-07-09 Augusta University Research Institute, Inc. Methods and compositions for inhibiting Akt3
US11291719B2 (en) * 2016-01-15 2022-04-05 Augusta University Research Institute, Inc. Methods and compositions for modulating Akt3
EP3678666B1 (en) * 2017-09-07 2025-07-09 Augusta University Research Institute, Inc. Specific akt3 activator and uses thereof
WO2020168241A1 (en) * 2019-02-15 2020-08-20 Flagship Pioneering Inc. X-reactivation modulators and uses thereof

Similar Documents

Publication Publication Date Title
JP2024540107A5 (cg-RX-API-DMAC10.html)
CA2972014A1 (en) Fused pyrimidine compounds for the treatment of hiv
JP6554117B2 (ja) 医療で使用されるインドール誘導体
JP2023525757A5 (cg-RX-API-DMAC10.html)
CN111263767B (zh) 作为干扰素基因调节剂的刺激剂的环状二核苷酸
US8815918B2 (en) Imidazo [2, 1-B] [1, 3, 4] thiadiazole derivatives
JP2019501133A5 (cg-RX-API-DMAC10.html)
CY1115836T1 (el) Παραγωγα πυραζινονης και η χρηση τους στη θεραπευτικη αντιμετωπιση παθησεων των πνευμονων
JP2022505835A5 (cg-RX-API-DMAC10.html)
JP2022516469A5 (cg-RX-API-DMAC10.html)
CY1119865T1 (el) Φαρμακευτικες συνθεσεις για την αντιμετωπιση της νοσου του παρκινσον
JP2013535460A5 (cg-RX-API-DMAC10.html)
CA2643177A1 (en) Multi-cyclic compounds for treating cancer
BR0316407A (pt) Derivados de nucleosìdeo antiviral
JP2016529324A5 (cg-RX-API-DMAC10.html)
JP2021535112A5 (cg-RX-API-DMAC10.html)
BRPI0820112B8 (pt) derivados de isoxazol-piridina, seu uso e processos de preparação e medicamento
CY1113846T1 (el) Παραγωγα πυριμιδινης για την θεραπευτικη αντιμετωπιση του ασθματος, copd, αλλεργικης ρινιτιδας, αλλεργικης επιπεφυκιτιδας, ατοπικης δερματιτιδας, καρκινου, ηπατιτιδας β, ηπατιτιδας c, hiv, hpv, βακτηριακων λοιμωξεων και δερματωσης
RU2011108024A (ru) 3-азабицикло(3.1.0) гексильные производные в качестве модуляторов метаботропных глутаматных рецепторов
JP2023164918A5 (cg-RX-API-DMAC10.html)
JP2017520571A5 (cg-RX-API-DMAC10.html)
JP2014510147A5 (cg-RX-API-DMAC10.html)
JP2025505644A5 (cg-RX-API-DMAC10.html)
RU2010140613A (ru) Амиды диазабициклоалканов, селективные в отношении подтипа никотиновых ацетилхолиновых рецепторов
JP2022511477A5 (cg-RX-API-DMAC10.html)